Butterfly iQ/iQ+ Ultrasound System vs Fibresolve (with PCCP)

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 60/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
Butterfly iQ/iQ+ Ultrasound System
by Butterfly Network
VS
Fibresolve (with PCCP)
by Imvaria

AI Verdict

These tools are adjacent in their comparability, both leveraging AI for diagnostic support in medical imaging, but they serve distinct primary functions. Butterfly iQ/iQ+ is a portable ultrasound system for real-time, whole-body imaging, while Fibresolve is a cloud-based AI service that analyzes existing CT scans specifically for lung fibrosis diagnosis. Therefore, the choice between them depends on whether real-time, point-of-care ultrasound imaging or specialized AI-driven CT scan analysis for lung conditions is required.

Choose Butterfly iQ/iQ+ Ultrasound System if…

Choose the Butterfly iQ/iQ+ Ultrasound System if you need a versatile, portable, and cost-effective point-of-care ultrasound solution for a wide range of clinical applications. Its single-probe, whole-body imaging capabilities, compatibility with mobile devices, and AI-powered tools make it ideal for bedside diagnoses, procedural guidance, and use in diverse settings like emergency medicine, critical care, and even rural communities.

View Butterfly iQ/iQ+ Ultrasound System →

Choose Fibresolve (with PCCP) if…

Choose Fibresolve (with PCCP) if your primary need is an AI-driven diagnostic tool for the non-invasive assessment and subtype classification of lung fibrosis, particularly Idiopathic Pulmonary Fibrosis (IPF), using standard chest CT scans. This tool is best suited for pulmonologists and radiologists seeking to augment their clinical expertise and potentially expedite accurate diagnoses in challenging ILD and IPF cases before invasive testing.

View Fibresolve (with PCCP) →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature Butterfly iQ/iQ+ Ultrasound System Fibresolve (with PCCP)
Pricing Device purchase + mandatory annual subscription. Contact vendor for pricing.
Deployment Mobile device (iOS/Android) connected to a handheld probe, with cloud-based software. Cloud-based centralized service.
BAA Available Yes AI-estimated Unknown
FDA Status Yes AI-estimated 1 AI-estimated
HIPAA Yes AI-estimated Unknown

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Butterfly iQ/iQ+ Ultrasound System

Butterfly iQ/iQ+ is designed for ease of use with a single handheld probe, mobile device compatibility, and AI-powered tools like Auto Bladder Volume Capture, making it highly accessible for point-of-care imaging. Fibresolve, while 'integration-free,' is a cloud-based analysis tool for CT scans, implying a more specialized workflow for radiologists or pulmonologists rather than general clinical use.

Clinical Value

Butterfly iQ/iQ+ Ultrasound System

Butterfly iQ/iQ+ offers immediate, real-time diagnostic imaging across 20+ anatomical presets and six imaging modes, providing broad utility in critical care, emergency medicine, and general diagnostics. Fibresolve focuses on a specific, albeit important, diagnostic area (lung fibrosis), making its clinical value more niche compared to the versatile, whole-body imaging capabilities of Butterfly iQ/iQ+.

Pricing & Value

Butterfly iQ/iQ+ Ultrasound System

Butterfly iQ/iQ+ has transparent pricing with a device purchase and a mandatory annual subscription, allowing users to clearly understand the cost of ownership. Fibresolve requires contacting the vendor for pricing, which makes it difficult to assess its value proposition without specific cost information.

Enterprise Readiness

Butterfly iQ/iQ+ Ultrasound System

Butterfly iQ/iQ+ explicitly states HIPAA and GDPR compliance, offers unlimited cloud storage, and has teleguidance functionality, indicating robust features for enterprise deployment and data management. While Fibresolve is FDA-authorized and likely HIPAA compliant, the lack of explicit statements on BAA and detailed enterprise features makes Butterfly iQ/iQ+ appear more ready for large-scale organizational adoption.

Innovation

Butterfly iQ/iQ+ Ultrasound System

Butterfly iQ/iQ+ features groundbreaking Ultrasound-on-Chipu2122 technology, replacing multiple traditional probes with a single silicon chip for whole-body imaging, which is a significant technological leap. Fibresolve's AI-driven analysis of CT scans for lung fibrosis is innovative, but the fundamental 'Ultrasound-on-Chip' concept represents a more disruptive innovation in medical imaging hardware.

Support & Docs

Tie

Neither product's provided information explicitly details their support channels, documentation availability, or training programs. While both are FDA-cleared medical devices, implying a certain level of support, there isn't enough information to differentiate between them on this dimension.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature Butterfly iQ/iQ+ Ultrasound System Fibresolve (with PCCP)
Company Butterfly Network Imvaria
Product Name Butterfly iQ/iQ+ Ultrasound System Fibresolve (with PCCP)
Primary Function Handheld, single-probe, whole-body ultrasound system leveraging Ultrasound-on-Chipu2122 technology and AI-powered tools for accessible, high-quality diagnostic imaging on mobile devices. AI-driven diagnostic tool for lung fibrosis, analyzing standard chest CT scans to provide diagnostic subtype classification and adjunctive information for clinicians.
Key Specialties Critical Care, Emergency Medicine, Radiology Pulmonology, Radiology
Unique Technology/Features Ultrasound-on-Chipu2122 Technology (single silicon chip replaces multiple probes), Whole-body imaging with a single handheld probe, AI-powered imaging tools (Auto Bladder Volume Capture, Auto B-Line Counter, NeedleVizu2122), Teleguidance functionality. AI-driven diagnostic tool for lung fibrosis, Non-invasive assessment of ILD and IPF, Analyzes standard chest CT scans, FDA-authorized and Breakthrough-Designated, Associated with CPT billing codes by the AMA.

Videos

Demos, reviews, and walkthroughs featuring Butterfly iQ/iQ+ Ultrasound System and Fibresolve (with PCCP).

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

The Butterfly iQ/iQ+ is a handheld ultrasound system that connects to mobile devices, allowing for point-of-care imaging and integration with imaging workflows and data management tools. Fibresolve, on the other hand, is designed for an integration-free workflow, analyzing standard chest CT scans.
Fibresolve has demonstrated a sensitivity of 76.5% for the non-invasive classification of Idiopathic Pulmonary Fibrosis (IPF) in patients with a non-definite Usual Interstitial Pneumonia (UIP) radiographic pattern by HRCT. It can positively identify cases of IPF with high sensitivity, serving as an adjunct in the non-invasive diagnosis of IPF when combined with standard clinical assessment.
The Butterfly iQ/iQ+ is designed to be easy to use, with a user-friendly interface on its mobile app and 20+ presets that can be selected in seconds. This suggests a relatively low learning curve, enabling quick adoption for various imaging needs.
Butterfly Network provides tutorials, training packages, and courses created by their experts for the Butterfly iQ/iQ+ system. Information regarding specific support and training for Fibresolve is not detailed in the provided facts.
The Butterfly iQ/iQ+ can help healthcare providers save time in diagnosis and treatment due to its faster frame rates and sharper imaging, potentially improving patient outcomes. Fibresolve offers non-invasive assessment and diagnostic subtype classification for lung fibrosis, which could lead to earlier and more accurate diagnoses, though specific time-to-value metrics are not provided.
The provided information does not explicitly detail audit-trail features for either the Butterfly iQ/iQ+ or Fibresolve. However, EHR audit trail logs are generally used to record clinicians' EHR interactions for security and privacy purposes and can be used to analyze clinical workflow.
The Butterfly iQ/iQ+ is a highly portable, handheld device that connects to mobile phones, making it suitable for use in diverse settings, including remote locations. This inherent portability would likely simplify multi-site rollouts. Fibresolve is a cloud-based centralized service, which generally facilitates multi-site access and deployment, but specific rollout considerations are not detailed.

More Comparisons

eCARTv5 Clinical Deterioration Suite (“eCART”) vs Google Med-PaLM 2
ChatGPT vs Google Med-PaLM 2
When choosing between ChatGPT and Google Med-PaLM 2, physicians should consider their primary use case and desired level of medical…
Brainomix 360 e-CTA vs Google Med-PaLM 2
DeepXray vs Google Med-PaLM 2

More matchups featuring Butterfly iQ/iQ+ Ultrasound System or Fibresolve (with PCCP)

Backers

Who funded each tool's parent company.

Fibresolve (with PCCP)

AI Tool Finder
AI-powered search. Results may not be comprehensive.